Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,081,150
-$42,540 QoQ
Shares Held
4,257
-7.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,250
of 2,126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CREATIVE FINANCIAL DESIGNS INC /ADV holds $42,475,367 across 16 Drug Manufacturers - General names. JNJ ranks #4 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,603 | $35,506,729 | |
| 2 | AMGN |
Amgen Inc
|
6,017 | $2,178,876 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,797 | $2,158,414 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
4,257 | $1,081,150 | |
| 5 | ABBV |
AbbVie Inc.
|
1,839 | $462,765 | |
| 6 | PFE |
Pfizer Inc
|
14,841 | $357,371 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,696 | $340,612 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,756 | $216,420 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,081,150 | 4,257 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,123,690 | 4,597 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $959,420 | 4,636 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $847,183 | 4,569 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,080,400 | 7,073 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,832,366 | 11,049 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,375,191 | 9,509 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,432,772 | 8,841 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,082,899 | 7,409 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,043,421 | 6,596 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,116,929 | 7,126 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,105,046 | 7,095 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,165,591 | 7,042 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $329,375 | 2,125 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $622,867 | 3,526 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $617,990 | 3,783 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $627,675 | 3,536 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $414,718 | 2,340 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $346,758 | 2,027 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $451,554 | 2,796 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $510,364 | 3,098 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $509,978 | 3,103 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $527,223 | 3,350 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $506,192 | 3,400 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $408,389 | 2,904 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $200,760 | 1,531 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||